Vendor, Blue Bell, PA
Mitochon Pharmaceuticals, Inc.
UEI JGJ7TELAKUY8, CAGE 7NNV1
1 award and $50,000 obligated between November 7, 2024 and November 7, 2024, 0% under full and open competition, against 1.0 offers on average where reported. 1 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $50,000 |
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Notice of Intent to Sole Source MP201 Drug Synthesis
Defense Health Agency (Dha), Army Med Res Acq Activity
Special noticeNAICS 541715Silver Spring, MDHT9425-24-Q-0095Awarded to Mitochon Pharmaceuticals, Inc.
Posted Jul 11, 2024
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HT942525P0014Purchase Order, November 7, 2024, Not Competed Under SAP, 1 offersSolicitation | Army Med Res Acq ActivityDefense Health Agency | MP201 Drug Development/SynthesisNAICS 541715, PSC AN14 | $50,000 |
- Places of performance
- Maryland
- Product and service codes
- AN14 Health R&D Services; Health Care Services; R&D Administrative Expenses
- Transactions
- 1 across 1 awards